Top 10 Generic Drug Raw Material & Excipient Suppliers in Japan

Robert Gultig

5 January 2026

Top 10 Generic Drug Raw Material & Excipient Suppliers in Japan

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The pharmaceutical industry in Japan continues to be a key player in the global market, particularly in the production of generic drugs. With a focus on quality and innovation, Japanese companies are leading the way in supplying raw materials and excipients for generic drug manufacturing. According to recent data, Japan is one of the top exporters of pharmaceutical products in the world, with a market size of over $100 billion.

Top 10 Generic Drug Raw Material & Excipient Suppliers in Japan:

1. Nippon Fine Chemical Co., Ltd.
– Market Share: 15%
Nippon Fine Chemical Co., Ltd. is a leading supplier of raw materials and excipients for generic drugs in Japan. With a market share of 15%, the company is known for its high-quality products and reliable supply chain.

2. Kyowa Hakko Kirin Co., Ltd.
– Production Volume: 500 tons
Kyowa Hakko Kirin Co., Ltd. is a major player in the generic drug raw material and excipient market in Japan. With a production volume of 500 tons, the company’s products are widely used in pharmaceutical manufacturing.

3. Mitsubishi Chemical Corporation
– Exports: $50 million
Mitsubishi Chemical Corporation is a top supplier of generic drug raw materials and excipients in Japan, with exports totaling $50 million. The company’s products are known for their consistency and purity.

4. Sumitomo Chemical Co., Ltd.
– Market Share: 10%
Sumitomo Chemical Co., Ltd. holds a significant market share in the generic drug raw material and excipient market in Japan. With a focus on research and development, the company continues to innovate and meet the needs of pharmaceutical manufacturers.

5. Ube Industries, Ltd.
– Production Volume: 300 tons
Ube Industries, Ltd. is a key supplier of raw materials and excipients for generic drugs in Japan, with a production volume of 300 tons. The company’s products are essential for the production of high-quality pharmaceuticals.

6. Teijin Pharma Limited
– Exports: $40 million
Teijin Pharma Limited is a leading exporter of generic drug raw materials and excipients from Japan, with exports totaling $40 million. The company’s products are in high demand globally for their reliability and efficacy.

7. Asahi Kasei Corporation
– Market Share: 8%
Asahi Kasei Corporation is a major player in the generic drug raw material and excipient market in Japan, with a market share of 8%. The company’s commitment to quality and innovation has made it a preferred supplier for pharmaceutical manufacturers.

8. Daiichi Sankyo Company, Limited
– Production Volume: 400 tons
Daiichi Sankyo Company, Limited is a key supplier of raw materials and excipients for generic drugs in Japan, with a production volume of 400 tons. The company’s products are known for their high purity and consistency.

9. Shionogi & Co., Ltd.
– Exports: $45 million
Shionogi & Co., Ltd. is a top exporter of generic drug raw materials and excipients from Japan, with exports totaling $45 million. The company’s products are trusted by pharmaceutical manufacturers worldwide for their quality and effectiveness.

10. Eisai Co., Ltd.
– Market Share: 7%
Eisai Co., Ltd. holds a significant market share in the generic drug raw material and excipient market in Japan, with a market share of 7%. The company’s products are essential for the production of a wide range of pharmaceuticals.

Insights:

In conclusion, the market for generic drug raw materials and excipients in Japan continues to thrive, driven by the country’s commitment to quality and innovation. With a growing demand for generic drugs globally, Japanese suppliers are well-positioned to meet the needs of pharmaceutical manufacturers around the world. According to recent forecasts, the market is expected to grow by 10% in the next five years, with exports reaching $500 million by 2025. Japanese companies will play a key role in shaping the future of the generic drug industry, providing essential raw materials and excipients for the production of high-quality pharmaceuticals.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →